american health care after sgr - chop: coalition of...
TRANSCRIPT
© 2013 American Medical Association. All rights reserved.
American Health Care After SGR Coalition of Hematology Oncology Practices
Barbara McAneny MD
© 2013 American Medical Association. All rights reserved.
U.S. Health Care Spending
• More than $2 trillion • $7,681 per person • 16.2% of gross domestic
product
Each year the U.S. spends:
© 2013 American Medical Association. All rights reserved.
Global Growth in Spending
© 2013 American Medical Association. All rights reserved.
Medicare Expenditures
© 2013 American Medical Association. All rights reserved.
© 2013 American Medical Association. All rights reserved.
Medicare payment vs. practice cost inflation
© 2013 American Medical Association. All rights reserved.
© 2013 American Medical Association. All rights reserved.
AMA Strategy to Reduce Costs
1) Reduce burden of preventable disease
2) Make the delivery of care more efficient
3) Reduce nonclinical costs that don't contribute to patient care
4) Promote value-based decision-making at all levels
Goal: To get the most for our health care dollars, rather than reduce costs alone
© 2013 American Medical Association. All rights reserved.
9
The problem
Yes
Source: NCPDP Prior Authorization Workflow-to-Transactions Task Group, 2005
Patient Visits Prescriber
Prescriber writes Rx for preferred drug
therapy
Patient takes Rx to pharmacy
Prescriber transmits Rx to
pharmacy or calls
Pharmacy enters Rx, claim filled with plan
Plan identifies drug as requiring PA, rejects claim & responds to pharmacy
or calls prescriber
Pharmacy contacts prescriber or submits
request if it has information
Prescriber contacts plan to obtain
correct form or looks up in book
New PA
Prescriber completes form, faxes to plan or provides info via
phone
Plan reviews PA request
Prescriber contacts
pharmacy with new Rx
Rx Dispensed
Prescriber contacts pharmacy indicating
PA request was approved, OK to
dispense
Plan contacts prescriber
approving PA
Plan contacts prescriber, asks for
more info
Does 2nd
drug require
PA?
Select 2nd drug?
Patient pays for all costs
No Rx therapy
Plan contacts prescriber denying
PA request
New PA
Are all PA questions
answered?
Approve PA Request?
Yes NoYes
No
NoNo
No
Yes
Yes
© 2013 American Medical Association. All rights reserved.
Reduce Preventable Disease • Train physicians on lifestyle
counseling • Expand insurance coverage for
prevention • Explore rewards-based
incentive programs • Promote public health
campaigns
of health care spending is on patients with chronic conditions
75%
© 2013 American Medical Association. All rights reserved.
Are you Prediabetic?
• Male 1 point
• Female 0 points
11
© 2013 American Medical Association. All rights reserved.
Are you Prediabetic?
• Male 1 point
• Female 0 points
• Over 60? 3 points
• 50-60? 2 points
• 40-50? 1 point
12
© 2013 American Medical Association. All rights reserved.
Are you Prediabetic? • Male 1 point • Female 0 points
• Over 60? 3 points • 50-60? 2 points • 40-50? 1 point
• Not Physically active? 1 point
13
© 2013 American Medical Association. All rights reserved.
Are you Prediabetic? • Male 1 point • Female 0 points
• Over 60? 3 points • 50-60? 2 points • 40-50? 1 point
• Not Physically active? 1 point • Diabetes in family? 1 point
14
© 2013 American Medical Association. All rights reserved.
Are you Prediabetic? • Male 1 point • Female 0 points
• Over 60? 3 points • 50-60? 2 points • 40-50? 1 point
• Not Physically active? 1 point • Diabetes in family? 1 point • Hypertension? 1 point
15
© 2013 American Medical Association. All rights reserved.
Body Habitus
0 1 2 3
Opioid Abuse Prevention
17
© 2013 American Medical Association. All rights reserved.
Ama-assn.org/go/endopioidabuse • 44 RX Opioid Deaths per day
• Use Prescription Drug Monitoring Programs
• Effective physician education on prescribing
• Reduce stigma of chronic pain
• Reduce stigma of substance abuse
• Expand use of naloxone for overdose
• Work with administration for treatment dollars
18
© 2013 American Medical Association. All rights reserved.
Confronting the Opioid Epidemic
19
© 2013 American Medical Association. All rights reserved.
January 2015
The MACRA Framework
© 2013 American Medical Association. All rights reserved.
MACRA overview
The Medicare Access and CHIP Reauthorization Act
of 2015 (MACRA)
Developed in bipartisan, bicameral process over 2+ years
Supported by over 750 national and
state-based physician organizations
Passed with overwhelming
bipartisan support
21
© 2013 American Medical Association. All rights reserved.
What MACRA does Permanently eliminates the SGR (and its annual physician payment cuts)
Establishes a path for alternative payment models (APMs)
Consolidates reporting programs
22
© 2013 American Medical Association. All rights reserved.
Physicians will have choices
Fee-for-Service under a “Merit-based Incentive
Program” (MIPS)
Alternative Payment Models
• Statutory updates
• Consolidated reporting
• Reduced penalty risk
• Higher updates
• Exempt from MIPS
• Preferred treatment for medical homes
• Specialty models encouraged
23
© 2013 American Medical Association. All rights reserved.
Annual payment updates
• 2015: 0.5% update provided July 1, in lieu of -21.2% cut on April 1
• 2016-2019: 0.5% update provided on Jan. 1 each year
• 2020-2025: 0% update • 2026 and beyond: 0.25%
annual updates in FFS; 0.75% annual updates for APMs
• There is no more SGR cliff
• Last short-term patch (PAMA) in 2014 set savings targets for revising misvalued codes – 0.5% savings per year, 2017-2020
• ABLE Act accelerated targets – 1.0% in 2016, 0.5% in 2017 and
2018
• Final 2016 fee schedule rule issued Oct. 30 announced -0.29% (10 cents) payment cut in 2016
24
MACRA provisions Reality check
The Merit-based
Incentive Payment
System (MIPS)
25
© 2016 American Medical Association. All rights reserved.
Components of the Merit-based Incentive Payment
System (MIPS)
Quality Measurement (PQRS)
Resource Use (Value-based Modifier)
EHR Meaningful Use Clinical practice
improvement activities
MIPS
26
© 2016 American Medical Association. All rights reserved.
Relative weights of MIPS components
2019 2020 2021 2022 onward
Quality
(PQRS)
50% 45% 30% 30%
Resource use
(VBM)
10% 15% 30% 30%
MU* 25% 25% 25% 25%
CPI 15% 15% 15% 15%
Penalty risk -4% -5% -7% -9%
27
*MU weight may be reduced to 15% if 75% of EPs are successful
© 2016 American Medical Association. All rights reserved.
MIPS performance assessment
• CMS compares each EP’s or group’s performance to an annual “performance threshold,” calculates a “composite performance score,” and arrives at a percentage “adjustment factor.”
Adjustment factor
• MIPS measures and scoring must be adjusted for “an individual’s health status and other risk factors.”
Risk adjustment
• Annual threshold is based on median or mean composite scores of all EPs in a prior period. (Cannot be used as a standard of care for medical liability actions.)
Performance threshold
• At the threshold: no adjustment
• Above the threshold: bonus
• Below the threshold: penalty
Penalty or bonus
28
© 2016 American Medical Association. All rights reserved.
MIPS performance assessment
• 2019: + 4%; 2020: + 5%; 2021: + 7%; 2022 and after: + 9%
• Bonuses may be adjusted (somewhat) so that total bonuses = total penalties
Range of adjustments
• Extra bonus up to 10%, $500 million per year, 2019-1025 for scoring in top 25% above threshold.
Exceptional performance bonus
• CMS can weight categories differently (even zero) if there are insufficient measures and activities for an EP type.
Flexible weight categories
• EP/group must be told their adjustment factor at least 30 days before next performance period (i.e., by Dec. 1). Notification
29
© 2016 American Medical Association. All rights reserved.
Who must report under the MIPS?
MIPS eligible professionals (EPs) in 2019:
•Physicians, podiatrists, optometrists, chiropractors, physician assistants, nurse practitioners, clinical nurse specialists & nurse anesthetists.
Starting 2021, MIPS EPs could include:
•Social workers, psychologists, dietitians, nutritionists, physical therapists, occupational therapists, speech pathologists & audiologists.
Who does not have to report under MIPS?
•EPs:
• In qualifying alternative payment models.
•W/Medicare claims or patients below “low volume threshold.”
• In 1st year of Medicare enrollment.
•Clinicians who are not EPs.
EPs who do not report:
•Get the maximum MIPS penalty:
• 4% in 2019
• 5% in 2020
• 7% in 2021;
• 9% in 2022 & after.
30
© 2016 American Medical Association. All rights reserved.
2019 (first year) penalty risks compared
31
Prior Law 2019
adjustments
PQRS -2%
MU -5%
VBM -4% or more*
Total penalty risk -11% or more*
Bonus potential (VBM
only)
Unknown (budget
neutral)*
MIPS factors 2019 scoring
Quality measurement 50% of score
MU 25% of score
Resource use 10% of score
Clinical improvement
activities
15% of score
Total penalty risk Max of -4%
Bonus potential Max of 4%, plus
potential 10% for high
performers *VBM was in effect for 3 years before MACRA
passed, and penalty risk was increased in each of
these years; there were no ceilings or floors on
penalties and bonuses, only a budget neutrality
requirement.
© 2016 American Medical Association. All rights reserved.
More on MIPS components
•Small practices (up to 10) may join “virtual groups”
•CMS may OK alternative measures and activities for those who do not see patients
•Reporting via EHRs and registries encouraged PQRS (30%)
•CMS to develop care episode, patient condition, and patient relationships categories for accurate calculations and attributions
•Charges to include Parts A and B, perhaps Part D drugs if feasible Resource use (30%)
•Acting CMS Administrator announced that MU in present form will end in 2016, to favor patient outcomes over reporting tasks
•Goal for achieving interoperability of EHRs set for 2018
Meaningful Use (25%)
•New category; options mentioned include: expanded practice access, population management, care coordination (e.g., remote monitoring, telehealth), beneficiary engagement, patient safety and practice assessment, participation in APMs.
Clinical improvement activities (15%)
32
© 2016 American Medical Association. All rights reserved.
AMA Work on Meaningful Use
• Shortened the 2015 Reporting Period
• Reduced the measure threshold for the requirements for patients to
view, download or transmit their records
• Reduced the threshold for secure messaging requirement
• Secured passage of the Patient Access and Medicare Protection Act
– Allowed CMS to expedite exemptions from MU 2 Stage 2 for 2015
33
© 2016 American Medical Association. All rights reserved.
Break the Red Tape: Meaningful Use
34
Alternative payment
models (APMs)
35
© 2016 American Medical Association. All rights reserved.
Alternative payment models (APMs) under MACRA
Incentives for APM
participation
• Better payment potential inherent in model design.
• 2019-2024: EPs get a 5% bonus for participation in qualifying APMs.
• 2026 & after: Annual payment update is 0.75% for EPs in APMs, 0.25% for others.
• No MIPS reporting.
Qualifying APMs
• MSSP accountable care organizations, CMMI initiatives (not Health Care Innovation awards) & certain demonstration programs.
• New APMs must require use of a certified EHRs & have quality measures.
• Must bear “more than nominal” financial risk, except CMMI medical homes.
36
© 2016 American Medical Association. All rights reserved.
Alternative payment models (APMs) under MACRA
Level of participation required for incentives
• APM revenue or patients must be at least 25% in 2019-20 – rising to 75% by 2023.
• EPs can qualify with non-Medicare APMs & “partially qualify” for getting close to thresholds.
• CMS can extrapolate from partial year revenue.
Advisory Committee &
CMS Study
• New Physician-focused Payment Model Technical Advisory Committee reviews proposals for new APMs & make recommendations.
• CMS must issue study by July 2016 of feasibility of integrating APMs into Medicare Advantage, adding a VBM & if it should be budget-neutral.
37
© 2016 American Medical Association. All rights reserved.
An AMA menu of physician-focused APMs
• Payments for high-value services
• Condition-based payment for a physician’s services
• Multi-physician bundled payment
• Physician-facility procedure bundle
• Warrantied payment for physician services
• Episode payment for a procedure
• Condition-based payment
38
What’s next?
39
© 2016 American Medical Association. All rights reserved.
Milestone events
2016 •Proposed rule (March?) and final regulations (September?) issued for MIPS
2017
•First performance measurement year for MIPS
•APM criteria set, proposals accepted for review on an ongoing basis
2018
•First performance measurement year for APMs
•Separate PQRS, MU, and VBM programs/ adjustments sunset Dec. 31
•Deadline for achieving EHR interoperability Dec. 31
2019
•First MIPS payment adjustments implemented, maximum bonus/ penalty + 4% (phases up to + 9% in 2022)
•First APM performance assessed, 5% bonus payments made to “qualifying participants”
•HHS reports if EHR interoperability achieved, penalties and decertification criteria may be recommended
40
© 2016 American Medical Association. All rights reserved.
AMA Plans
• Goal: To proactively shape MACRA implementation so that all
physicians can succeed under the practice model of their choice
• Work collaboratively with physician specialty organizations and state
medical societies (MACRA task force, MIPS and APM workgroups) to
promote common recommendations and physician engagement
• Conduct outreach to other influential stakeholders and find common
ground
• Secure needed external expertise
41
© 2016 American Medical Association. All rights reserved.
Early consensus points for medicine
• It is important for MACRA to succeed
– Requires broad participation by medicine, constructive engagement with CMS
• MIPS must not simply combine current pay for performance/ reporting programs
– Programs need to be reformed, aligned, simplified
– Redirecting the Meaningful Use program is a top priority
• Diverse set of APMs needed, but common elements must be identified
– Don’t reinvent the wheel for each specialty
• Physicians need tools, resources, decision trees
42
© 2016 American Medical Association. All rights reserved.
Some important questions remain
• Will MIPS components be sufficiently improved?
• Will there be enough qualified APMs?
• Will “Physician-Focused Payment Models” qualify for the APM bonus
payments?
• How will “more than nominal risk” be identified?
• How frequently, in what format, and through what means will
performance feedback be provided to physicians?
• Does CMS have the necessary capabilities and bandwidth to implement
such a complex law?
43
© 2016 American Medical Association. All rights reserved.
CMMI Oncology Care Model (OCM) Patient Population:
• The CMMI OCM Payment Model applies to all patients with a new chemotherapy start.
Episode Definition:
• 6 months following new chemotherapy start, repeatable.
Payments
• The OCM model will pay physicians in three ways:
– Normal FFS Payments
– $160 PBPM (per beneficiary per month)
– Shared Savings/Risk Sharing
Episode Price/Discount to Medicare
• 4% discount for practices participating in shared savings
• 2.75% discount for practices accepting full risk
The COME HOME Program – External Evaluation, Evolving Outcomes
January 2016
www.innovativeobs.com
Methods
• Data collected from October 2012 – March 2015
• COME HOME patients compared to matched controls
• Analytic method: Difference in Differences (DID) analysis, which normalizes all utilization during the study period to normalization of those same patients before COME HOME
• Patient count: 3,663 Medicare FFS patients vs. matched controls
© 2016 American Medical Association. All rights reserved.
Quantitative Findings (quarterly)
• 10 ED Visits avoided per 1,000 patients**
• 3 acute care sensitive hospitalizations avoided per 1,000 patients*
• 4 readmissions avoided per 1,000 admissions*
• $673 reduction in total cost of care ($224 PMPM)**
*p<0.1
**p<0.05
© 2016 American Medical Association. All rights reserved.
What might the OCM look like for a community oncology practice?
($200,000.00)
($150,000.00)
($100,000.00)
($50,000.00)
$0.00
$50,000.00
$100,000.00
$150,000.00
$200,000.00
$250,000.00
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Qu
arte
rly
Ris
k B
ase
d P
aym
en
t
Quarter
Shared Savings (Upside Only) Risk Based Payment (Full Risk)
AMA Advocacy in
Action
49
© 2016 American Medical Association. All rights reserved.
Blocking Health Insurer Consolidation
“The AMA believes patients are better served in a health care system that
promotes competition and choice. We have long cautioned about the
negative consequences of large health insurers pursuing merger strategies
to assume dominant positions in local markets. Recently proposed mergers
threaten to increase health insurer concentration, reduce competition and
decrease choice.”
Steven J. Stack, MD
President, American Medical Association
50
© 2016 American Medical Association. All rights reserved.
MARKET CONSOLIDATION:
5 PLANS NOW-----3 PLANS IN 2017?
• Competition in Health Insurance, 2015 AMA website
• Testimony before House Judiciary Committee
• Letter to Department of Justice to Block Mergers
• Engaged National Association of Attorneys General
• Collaboration with State and Specialty Medical Societies
• ama-assn.org/go/competition
• ama-assn.org/go/mergers
51
© 2016 American Medical Association. All rights reserved.
Other AMA Advocacy Efforts
• Supporting Medical Education
– Undergraduate and GME
• Drug Pricing Task Force
– Address pharmaceutical prices
– Advocacy campaign for public attention
• Network Advocacy
– Regulatory oversight of networks
– Developing measures, including hospital based physicians
52
© 2016 American Medical Association. All rights reserved.
Effects of ACA so far
• 39 Million Americans used a preventative or screening service without
copay or coinsurance
• 9 Million annual Wellness Visits
• 10.7 Million Medicare patients received $20.8B on prescription drugs
• Closing the Donut Hole (by 2020) helps all seniors, now with a $250
rebate
• 9 Million fewer Uninsured
• Large deductibles are a predictable problem
53
© 2016 American Medical Association. All rights reserved.
USP 800
• Punishing us to atone for New England Compounding
• Separate pressured rooms for “hazardous” and “non-hazardous” drugs
• Separate gowns and refrigerators and hoods
• Pressured receiving areas
• Planned for July 1 2018
54
© 2016 American Medical Association. All rights reserved.
55